Rockwell Medical (RMTI) Share-based Compensation Growth (1y) (2011 - 2026)
Rockwell Medical (RMTI) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 450.56% |
| Dec 31, 2025 | 1,532.14% |
| Sep 30, 2025 | -18.85% |
| Jun 30, 2025 | -22.50% |
| Dec 31, 2024 | -87.16% |
| Sep 30, 2024 | -39.08% |
| Jun 30, 2024 | 772.54% |
| Mar 31, 2024 | 677.20% |
| Dec 31, 2023 | -0.91% |
| Sep 30, 2023 | 303.39% |
| Jun 30, 2023 | -298.97% |
| Mar 31, 2023 | 207.82% |
| Dec 31, 2022 | -42.86% |
| Sep 30, 2022 | -50.97% |
| Jun 30, 2022 | -77.60% |
| Mar 31, 2022 | 24.15% |
| Mar 31, 2021 | -147.11% |
| Dec 31, 2019 | -46.12% |
| Sep 30, 2019 | 241.69% |
| Jun 30, 2019 | 9.96% |